In Other News

• Ultrathin Metasurface Could Bring Quantitative Phase Imaging to Portable Devices

• Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

• New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

• Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

• AI Uses H&E Slides to Predict Key Biomarkers Across 32 Cancers

• Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

• Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

• Surveillance and Susceptibility Testing Track Rising Candida Auris in U.S.

• New Chairside Oral Swab Test Could Guide Biopsy Decisions in Oral Cancer

• Plasma Cell-Free DNA Test Enables Earlier Diagnosis of Invasive Fungal Infections

• Multi-Protein Blood Test Improves Staging of Alzheimer’s Disease

• New Chairside Oral Swab Test Could Guide Biopsy Decisions in Oral Cancer

• Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

• AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

• AI Tool Identifies Slide Artifacts to Speed Digital Pathology Diagnosis

• Immune Biomarkers May Predict Recurrent Checkpoint Inhibitor Arthritis

• Collaboration Supports Global ADC Development with AI-Powered Tissue Analysis

• Plasma Cell-Free DNA Test Enables Earlier Diagnosis of Invasive Fungal Infections

• Immune Cell Blood Test May Predict Melanoma Immunotherapy Response

• Liquid Biopsy Combines Multiple Signals for Cancer Detection in a Single Analysis

• Compact Prenatal Screening System Expands Access to Preeclampsia Testing

• FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

• Newborn Screening Program Adds Spinal Muscular Atrophy Testing Across England